Regen Biopharma Pref Shs (RGBPP) Stock Price & News

All values in USD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	59.06K	59.37K	59.06K	59.06K
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	11.72K	210.00K	2.22K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	99.82K	170.70K	400.69K	210.56K
Operating expense	99.82K	182.42K	610.69K	212.77K
Total operating expenses	99.82K	182.42K	610.69K	212.77K
Operating income	-40.76K	-123.06K	-551.62K	-153.71K
Other non operating income	-89.26K	-349.22K	-380.83K	1.18M
EBT including unusual items	-167.29K	-572.47K	-967.85K	991.93K
EBT excluding unusual items	-167.29K	-572.47K	-967.85K	991.93K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-167.29K	-572.47K	-967.85K	991.93K
Net profit margin	-283.23%	-964.30%	-1,638.62%	1,679.38%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-37.28K	-100.20K	-35.40K	-36.04K
Net interest expenses	-37.28K	-100.20K	-35.40K	-36.04K
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance